// App-Quantinova.ai

P1334 : THE IMPACT OF IMMUNOSUPPRESSION ON RECONSTITUTION OF CMV-SPECIFIC T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Researchers

Presenter

  • Anna Dmitrova

Principal Investigators

  • Mikhail Drokov

  • Tatiana Tupoleva

  • Dmitriy Tikhomirov

  • Larisa Kuzmina

  • Murad Vagida

  • Grigoriy Efimov

  • Elena Parovichnikova

Medical Centers

  • Laboratory of transplantation immunology,National Research Center for Hematology,Moscow,Russische Fe

  • Bone marrow transplant,National Research Center for Hematology, Moscow, Russia,Moscow,Russian Federation

  • Laboratory of transplantation immunology,National Research Center for Hematology,Moscow,Russische Fe

  • Laboratory of cariology,National Research Center for Hematol

  • Head of National Research Center for Hematology,National Research Center for Hematology,Moscow,Russie, Fédération De

  • Bone Marrow Transplant Department, National Research Center for Hematology, Moscow, Russia

  • Immunotherapy and Post-BMT complications department,National Research Center for Hematology,Moscow,Russie, Fédération De

  • Immunotherapy and Post-BMT complications department,National Resear

  • Laboratory of virological diagnostics,National Research Center for Hematology,Moscow,Russische Federatie

  • Bone marrow transplant,National Research Center for Hematology, Moscow, Russia,Moscow,Russian Federation

  • Labo

  • Laboratory of cariology,National Research Center for Hematol

  • Head of National Research Center for Hematology,National Research Center for Hematology,Moscow,Russie, Fédération De

  • Chief of the National Research Center for Hematology,National Re

  • Immunotherapy and Post-BMT complications department,National Research Center for Hematology,Moscow,Russie, Fédération De

  • Department of Cytogenetics,National Research Center for Hematology,Moscow,Russie, Fédération De

Locations

  • United States

  • Russia

  • Philippines

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Chronic myelomonocytic leukemia

  • Acute lymphoblastic leukemia

  • Chronic Lymphocytic Leukemia

  • Chronic Myelogenous Leukemia

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Cytomegalovirus infection

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 2AP

  • Protein Tyrosine Phosphatase, Receptor Type C

  • Cluster of differentiation 8A

  • Soluble Complement 5b-9

  • Major Histocompatibility Complex, Class I, A

  • Major Histocompatibility Complex, Class I, B

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved